← back to search

C. Michael Stein

The University of Texas Southwestern Medical Center · US
Area of research
Pharmacology · Rheumatology
Research interest
Research focused on Mendelian randomization and Pharmacokinetics, with related work in Retrospective cohort study, Apixaban, Statin. Notable publications include 'Epicardial adipose tissue is increased in patients with systemic lupus erythematosus', 'Initiation of Tumor Necrosis Factor α Antagonists and Risk of Fractures in Patients With Selected Rheumatic and Autoimmune Diseases', and 'Serious Bleeding in Patients With Atrial Fibrillation Using Diltiazem With Apixaban or Rivaroxaban'.
h-index
—
citations
172
works
6
NIH funding
—
primary concept
—
email
✉ Find email ↗

Recent publications

Serious Bleeding in Patients With Atrial Fibrillation Using Diltiazem With Apixaban or Rivaroxaban
JAMA 2024cited by 27position: middledoi
Association between APOL1 risk variants and the occurrence of sepsis in Black patients hospitalized with infections: a retrospective cohort study
eLife 2023cited by 5position: middledoi
Statin-induced LDL cholesterol response and type 2 diabetes: a bidirectional two-sample Mendelian randomization study
The Pharmacogenomics Journal 2019cited by 25position: middledoi
Epicardial adipose tissue is increased in patients with systemic lupus erythematosus
Atherosclerosis 2012cited by 47position: middledoi
Initiation of Tumor Necrosis Factor α Antagonists and Risk of Fractures in Patients With Selected Rheumatic and Autoimmune Diseases
Arthritis Care & Research 2012cited by 47position: middledoi
Neuropsychometric correlates of efavirenz pharmacokinetics and pharmacogenetics following a single oral dose
British Journal of Clinical Pharmacology 2012cited by 21position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

— · 2 papers (2023–2024)QiPing Feng · Vanderbilt University2 papers (2019–2023)Cecilia P. Chung · University of Miami2 papers (2023–2024)— · 2 papers (2012–2012)Adriana M. Hung · National Institutes of Health2 papers (2023–2024)— · 2 papers (2012–2012)— · 2 papers (2012–2023)Edward P. Acosta · University of Alabama at Birmingham Hospital1 papers (2012–2012)Daniel Johnson · National Institute of Allergy and Infectious Diseases1 papers (2012–2012)Jeffrey R. Curtis · University of Alabama at Birmingham1 papers (2012–2012)Chesnal Arepalli · University of British Columbia1 papers (2012–2012)Bruce M. Psaty · Centre de recherche en Epidémiologie et Santé des Populations1 papers (2019–2019)J. Wouter Jukema · University of Palermo1 papers (2019–2019)— · 1 papers (2024–2024)Daniel I. Chasman · Harvard University1 papers (2019–2019)Aliza Lipson · Emory University1 papers (2012–2012)Paolo Raggi · University of Illinois Chicago1 papers (2012–2012)— · 1 papers (2012–2012)— · 1 papers (2024–2024)Marie R. Griffin · Vanderbilt University1 papers (2012–2012)